Bellevue Life Sciences Acquisition logo
Bellevue Life Sciences Acquisition
BLAC | NASDAQ
Chart Builder DCF Calculator
$3.01
-$3.72 (-55.27%)
At close: Feb 14, 2025, 04:00 PM ET

Bellevue Life Sciences Acquisition Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– -2.02M 403.78K -35.39K -3.31K -23.81K
– – – – – –
– – – – – –
– – 517.35K – 2.85K –
– -165.75K -2.78M – – –
– – – – – –
– – 1.55M 31.15K 2.85K –
– -2.19M -818.77K -4.24K -461 -23.81K
– – -4 – – –
– – – – – –
– – -70.39M – – –
– – 36.56M – – –
– 35.91M – – – –
– 35.91M -33.83M – – –
– – -1.15M 800K 100K –
– – -36M – – –
– – – – – –
– -33.67M 7.71M 7K 10K 86.47K
– -33.67M 34.54M 123.98K -57.44K 86.47K
– 50.72K -109.08K 119.74K -57.9K 62.65K
– -2.19M -818.77K -4.24K -461 -23.81K
– -2.19M -818.77K -4.24K -461 -23.81K
– – – – – –
– – -4 – – –
– -2.19M -818.77K -4.24K -461 -23.81K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.